AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2018
Jun 4, 2018
29821_dirs_2018-06-04_bfb3272e-cb0e-4b7a-a38c-212987a5867c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-06-01
Reporting Person: Pierce David A (EVP,Pres MedSurg)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-01 | Common Stock | M | 5000.0000 | $7.1600 | Acquired | 29201.0000 | Direct |
| 2018-06-01 | Common Stock | M | 2972.0000 | $0.0000 | Acquired | 32173.0000 | Direct |
| 2018-06-01 | Common Stock | F | 1322.0000 | $30.5900 | Disposed | 30851.0000 | Direct |
| 2018-06-01 | Common Stock | S | 5000.0000 | $30.5828 | Disposed | 25851.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-06-01 | Deferred Stock Units | $ | M | 2972.0000 | Disposed | 2021-06-01 | Common Stock (2972.0000) | Direct |
| 2018-06-01 | Stock Option (Right to Buy) | $7.1600 | M | 5000.0000 | Disposed | 2021-02-28 | Common Stock (5000.0000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant.
F4: Grant to the reporting person of an option to purchase 77,640 shares of common stock vesting in four annual increments beginning on February 28, 2012, the first anniversary of the grant.